-
-
Overview
-
Product performance
The use of this product to freeze and thaw stem cells has higher cell recovery rate and live cell recovery rate, higher cryopreservation effectiveness and higher safety, which helps to reduce the R&D cost and treatment cost of stem cell therapy and promote the rapid development of the stem cell pharmaceutical industry.
The positive markers of frozen and thawed stem cells are stably expressed, and the negative markers are not expressed, which effectively maintains the stemness of stem cells.
Features
· Developed based on controlled ice storage technology
· Double cryoprotectant, containing self-developed controlled ice protection agent + 10% USP grade DMSO
· Mesenchymal stem cell cryopreservation recovery rate>88%
· Obtained US FDA DMF registration
· Serum-free, protein-free, animal-free
· Full pharmacopoeia ingredients, clear components, pharmaceutical-grade raw materials
· Sterile, low endotoxin, <0.125 EU/mL
· High safety, high recovery rate, ultra-high ease of use
· Support ultra-high density cryopreservation, 1×10^5~5×107 cells/mL
· GMP grade
· Ready-to-use, can be stored and transported over long distances at 2~8°C
· Support direct freezing, no programmed cooling box required (Short-term storage: -80°C freezer. For long-term storage, transfer to -196°C liquid nitrogen after 12 hours.)Please contact us at for specific academic pricing.
More Details
-
- Properties
- Applications
-
Overview